
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [FOLD] Amicus Therapeutics Inc
Data updated 2025-Apr-22 (Tuesday)Compare current performance/technical metrics to history for Amicus Therapeutics Inc. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2025-Apr-22 Tuesday
Day Change | +2.98% Top | Day Volatility | 2.98% Low |
Streak | ↑ 1 day Mid | % Streak | +2.98% Mid |
RSI | 36 Low | CCI | -54.0 Mid |
MACD | 0.01 Mid | ATR | 0.36 Low |
ADX | 54.9 Top | SSO | 27.6 Mid |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +2.83% Mid | 4.83% Low | +1.47% Mid |
10-day | -3.36% Mid | 19.52% Mid | +2.57% Mid |
20-day | -20.48% Low | 40.48% Top | -6.80% Low |
50-day | -28.39% Low | 61.29% Top | -18.46% Low |
100-day | -28.47% Low | 67.10% Mid | -23.75% Low |
200-day | -29.56% Low | 104.03% Mid | -30.69% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2025-Apr-22, Amicus Therapeutics Inc had:daily change of +2.98% intraday volatility of 3.0% 1 ↑(up) day streak yielding +2.98% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2025-Apr-22 value annotated for comparison
Related to Amicus Therapeutics Inc
Information for Amicus Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-22 on Google
SEC Reports : Quarterly reports around 2025-May-22 on SEC Edgar
Compare Amicus Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Amicus Therapeutics Inc
Industry : Biotechnology industry performance which includes Amicus Therapeutics Inc